Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways

Central European Journal of Immunology

Volumn 40, Issue 3, 2015, Pages 373-379

  Zdanowski, Robert ^a   Krzyzowska, Małgorzata ^a   Ujazdowska, Dominika ^b   Lewicka, Aneta ^a   Lewicki, Sławomir ^a  

^a MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^b Research and Development Division Adamed Sp Z Oo ^*  (Poland)

Author keywords

Immune system; Intracellular signaling pathways; 7 nicotinic receptor

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE; MUSCARINIC RECEPTOR; NEUROTRANSMITTER; NICOTINIC RECEPTOR; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR;

ANTIGEN PRESENTATION; APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHOLINERGIC SYSTEM; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INTRACELLULAR SIGNALING; PROTEIN FUNCTION; REVIEW;

EID: 84944538861     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2015.54602     Document Type: Review

References (82)

1. Loewi O (1921): Über humerole übertragbarkeit der herzner-venwirkung. I. Mitteilung. Pflügers Arch Ges Physiol 189: 239-242.
2. Picciotto MR, Higley MJ, Mineur YS (2012): Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76: 116-129.
3. Fagerlund MJ, Eriksson LI (2009): Current concepts in neu-romuscular transmission. Br J Anaesth 103: 108-114.
4. Millar NS (2003): Assembly and subunit diversity of nicotin-ic acetylcholine receptors. Biochem Soc Trans 31: 869-874.
5. Albuquerque EX, Pereira EF, Alkondon M, et al. (2009): Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89: 73-120.
6. Sastry BV, Sadavongvivad C (1978): Cholinergic systems in non-nervous tissues. Pharmacol Rev 30: 65-132.
7. Zia S, Ndoye A, Lee TX, et al. (2000): Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 293: 973-981.
8. Kawashima K, Yoshikawa K, Fujii YX, et al. (2007): Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 80: 2314-2319.
9. Wang Y, Pereira EF, Maus AD, et al. (2001): Human bronchial epithelial and endothelial cells express α7 nicotinic ace-tylcholine receptors. Mol Pharmacol 60: 1201-1209.
10. Zia S, Ndoye A, Nguyen VT, et al. (1997): Nicotine enhances expression of the α3, α4, α5 and α7 nicotinic receptors modulating calcium metabolism and regulating adhesion and mo-tility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 97: 243-262.
11. Wessler I, Kirkpatrick CJ, Racke K (1998): Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77: 59-79.
12. Improgo MR, Soll LG, Tapper AR, et al. (2013): Nicotinic acetylcholine receptors mediate lung cancer growth. Front Physiol 4: 251.
13. Cooke JP, Ghebremariam YT (2008): Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis. Trends Cardio-vasc Med 18: 247-253.
14. de Jonge WJ, Ulloa L (2007): The alpha7 nicotinic acetylcho-line receptor as a pharmacologicaltarget for inflammation. Br J Pharmacol 151: 915-929.
15. Schirmer SU, Eckhardt I, Lau H, et al. (2011): The choliner-gic system in rat testis is of non-neuronal origin. Reproduction 142: 157-166.
16. Davis TJ, de Fiebre CM (2006): Alcohol's actions on neu-ronal nicotinic acetylcholine receptors. Alcohol Res Health 29: 179-185.
17. Reardon C, Duncan GS, Brüstle A, et al. Lymphocyte-derived ACh regulates local innate but not adaptive immunity. Proc Natl Acad Sci USA 110: 1410-1415.
18. Matteoli G, Boeckxstaens GE (2013): The vagal innervation of the gut and immune homeostasis. Gut 62: 1214-1222.
19. Sato KZ, Fujii T, Watanabe Y, et al. (1999): Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266: 17-20.
20. Skok MV, Kalashnik EN, Koval LN, et al. (2003): Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol Pharmacol 64: 885-889.
21. Sudheer PS, Hall JE, Donev R, et al. (2006): Nicotinic ace-tylcholine receptors on basophils and mast cells. Anaesthesia 61: 1170-1174.
22. Rosas-Ballina M, Ochani M, Parrish WR, et al. (2008): Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 105: 11008-11013.
23. Rosas-Ballina M, Olofsson PS, Ochani M, et al. (2011): Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit. Science 334: 98-101.
24. Olofsson PS, Katz DA, Rosas-Ballina M, et al. (2012): α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol Med 18: 539-543.
25. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, et al. (2008): Modulation of TNF release by choline requires al-pha7 subunit nicotinic acetylcholine receptor mediated signaling. Mol Med 14: 567-574.
26. Sun F, Jin K, Uteshev VV (2013): A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats. PLoS One 8: e73581.
27. Freitas K, Carroll FI, Damaj MI (2013): The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther 344: 264-275.
28. Wang H, Yu M, Ochani M, et al. (2003): Nicotinic acetylcho-line receptor-7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
29. Borovikova LV, Ivanova S, Zhang M, et al. (2000): Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
30. Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, et al. (2009): The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human mono-cytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15: 195-202.
31. Shytle RD, Mori T, Townsend K (2004): Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89: 337-343.
32. Kawashima K, Fujii T (2000): Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86: 29-48.
33. Kawashima K, Fujii T (2003): The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 74: 675-696.
34. Kawashima K, Fujii T (2004): Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 9: 2063-2685.
35. Fujii T, Tsuchiya T, Yamada S, et al. (1996): Localization and synthesis of acetylcholine in human leukemic T cell lines. J Neurosci Res 44: 66-72.
36. Wang DW, Zhou RB, Yao YM, et al. (2010): Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J Pharmacol Exp Ther 335: 553-561.
37. Nordman JC, Muldoon P, Clark S, et al. (2014): The α4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response. Mol Pharmacol 85: 50-61.
38. Nouri-Shirazi M, Tinajero R, Guinet E (2007): Nicotine alters the biological activities of developing mouse bone marrow-derived dendritic cells (Dcs). Immunol Lett 109: 155-164.
39. Vassallo R, Tamada K, Lau JS, (2005): Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 175: 2684-2691.
40. Nouri-Shirazi M, Guinet E (2012): Exposure to nicotine adversely affects the dendritic cell system and compromises host response to vaccination. J Immunol 188: 2359-2370.
41. Radosa J, Dyck W, Goerdt S, et al. (2011): The choliner-gic system in guttate psoriasis with special reference to mast cells. Exp Dermatol 20: 677-679.
42. Mishra NC, Rir-Sima-Ah J, Boyd RT, et al. (2010): Nicotine inhibits fc RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha7/alpha9/alpha10-nicotinic receptors. J Immunol 185: 588-596.
43. Kageyama-Yahara N, Suehiro Y, Yamamoto T, et al. (2009): IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem Biophys Res Commun 377: 321-325.
44. Huston JM, Rosas-Ballina M, Xue X, et al. (2009): Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 183: 552-559.
45. Gilboa-Geffen A, Lacoste PP, Soreq L, et al. (2007): The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. Blood 109: 4383-4391.
46. Gilboa-Geffen A, Wolf Y, Hanin G, et al. (2011): Activation of the alternative NFKB pathway improves disease symptoms in a model of Sjogren's syndrome. PLoS One 6: e28727.
47. Ofek K, Krabbe KS, Evron T, et al. (2007): Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med (Berl) 85: 1239-1251.
48. Brenner T, Hamra-Amitay Y, Evron T, et al. (2003): The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J 17: 214-222.
49. Nadorp B, Soreq H (2014): Predicted overlapping microR-NA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. Front Mol Neurosci 7: 9, doi: 10.3389/fnmol.2014.00009. eCollection 2014.
50. Perry C, Pick M, Podoly E, et al. (2007): Acetylcholines-terase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia 21: 1472-1480.
51. Couturier S, Bertrand D, Matter JM, et al. (1990): A neuronal nicotinic acetylcholine receptor subunit (alpha7) is devel-opmentally regulated and forms a homooligomeric channel blocked by alpha-BTX. Neuron 5: 847-856.
52. Smedlund K, Tano JY, Margiotta J, et al. (2011): Evidence for operation of nicotinic and muscarinic acetylcholine receptor-dependent survival pathways in human coronary artery endothelial cells. J Cell Biochem 112: 1978-1984.
53. Schuller HM, Plummer HK 3rd, Jull BA (2003): Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat Rec A Discov Mol Cell Evol Biol 270: 51-58.
54. Jull BA, Plummer HK 3rd, Schuller HM (2001): Nicotinic receptor-mediated activation by the tobacco-specific nitro-samine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol 127: 707-717.
55. Paulo JA, Brucker WJ, Hawrot E (2009): Proteomic analysis of an a7 nicotinic acetylcholine receptor interactome. J Pro-teome Res 8: 1849-1858.
56. Marrero MB, Bencherif M (2009): Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for an-ti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 1256: 1-7.
57. Tsurutani J, Castillo SS, Brognard J, et al. (2005): Tobacco components stimulate Akt-dependent proliferation and NFKB dependent survival in lung cancer cells. Carcinogenesis 26: 1182-1195.
58. de Jonge WJ, van der Zanden EP, The FO, et al. (2005): Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851.
59. Chernyavsky AI, Arredondo J, Karlsson E, et al. (2005): The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration. J Biol Chem 280: 39220-39228.
60. Trombino S, Cesario A, Margaritora S, et al. (2004): α7-nico-tinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res 64: 135-145.
61. Paleari L, Catassi A, Ciarlo M, et al. (2008): Role of al-pha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif 41: 936-959.
62. Wang H, Liao H, Ochani M, et al. (2004): Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
63. Terrando N, Eriksson LI, Ryu JK, et al. (2011): Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 70: 986-995.
64. Waldburger JM, Boyle DL, Pavlov VA, et al. (2008): Ace-tylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum 58: 3439-3449.
65. Al-Wadei MH, Al-Wadei HA, Schuller HM (2012): Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7. Mol Cancer Res 10: 239-249.
66. Nakamura S, Saitoh M, Yamazaki M, et al. (2010): Nicotine induces upregulated expression of beta defensin-2 via the p38MAPK pathway in the HaCaT human keratinocyte cell line. Med Mol Morphol 43: 204-210.
67. Li Q, Zhou XD, Kolosov VP, et al. (2011): Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-κB pathway in HBE16 airway epithelial cells. Cell Physiol Bio-chem 27: 605-612.
68. Carlisle DL, Hopkins TM, Gaither-Davis A, et al. (2004): Nicotine signals through muscle-type and neuronal nico-tinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res 5: 27, doi: 10.1186/1465-9921-5-27.
69. West KA, Brognard J, Clark AS, et al. (2003): Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111: 81-90.
70. Novak J, Escobedo-Morse A, Kelley K, et al. (2000): Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture. Lung Cancer 29: 1-10.
71. Lawlor MA, Alessi DR (2001): PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910.
72. Xin M, Deng X (2005): Nicotine inactivation of the proapop-totic function of Bax through phosphorylation. J Biol Chem 280: 10781-10789.
73. Scheid MP, Woodgett JR (2001): Pkb/akt: functional insights from genetic models. Nat Rev Mol Cell Biol 2: 760-768.
74. Kihara T, Shimohama S, Sawada H, et al. (2001): Alpha 7 nic-otinic receptor transduces signals to phosphatidylinositol 3-ki-nase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276: 13541-13546.
75. Carlisle DL, Liu X, Hopkins TM, et al. (2007): Nicotine activates cell-signaling pathways through muscle-type and neu-ronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther 20: 629-641.
76. Ueno H, Pradhan S, Schlessel D, et al. (2006): Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1. Cardiovasc Toxicol 6: 39-50.
77. Chatterjee PK, Al-Abed Y, Sherry B, et al. (2009): Cholin-ergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am J Physiol Cell Physiol 297: C1294-C12306.
78. Saeed RW, Varma S, Peng-Nemeroff T, et al. (2005): Choliner-gic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201: 1113-1123.
79. Chen RJ, Ho YS, Guo HR, et al. (2008): Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicol Sci 104: 283-293.
80. Chen RJ, Ho YS, Guo HR, et al. (2010): Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and be-ta-adrenoceptors in human bladder cancer cells. Toxicol Sci 115: 118-130.
81. Zeidler R, Albermann K, Lang S (2007): Nicotine and apop-tosis. Apoptosis 12: 1927-1943.
82. Jin Z, Gao F, Flagg T, et al. (2004): Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem 279: 23837-23844.